CUREMARK DIAGNOSTICS
DEAD

Serial Number

87505428

Owner

Curemark Diagnostics LLC

Attorney

Nicole K. McLaughlin

Filing Date

Jun 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

CUREMARK DIAGNOSTICS Trademark

Serial Number: 87505428

CUREMARK DIAGNOSTICS is a trademark filed by Curemark Diagnostics LLC on June 26, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Curemark Diagnostics LLC (3 trademarks)

Suite 206 South
Rye, NY 10580

Entity Type: 16

Trademark Details

Filing Date

June 26, 2017

Registration Date

Not Registered

Published for Opposition

May 22, 2018

Goods & Services

Biological preparations for medical testing, namely, biological preparations for the treatment of neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; pharmaceutical preparations, namely, enzymes, hormones and other biologicals, namely, neurotransmitter substances and immunological markers used to diagnose neurological diseases; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection, namely, neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing, namely, for neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders

Assays and reagents for use in medical research; biological substances, namely, urine, blood, feces, saliva, and lymph for scientific and medical research use; biological preparations for research purposes and for scientific testing; chemical preparations for scientific and research purposes

Medical consultations; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases

Design, development and administration of assays, namely, diagnostic assessment on bodily fluids for detection and determination of therapy for neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders, for the detection of enzymes or biological substances in humans; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 23, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 23, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2021 EXRA
SOU EXTENSION 5 GRANTED
Dec 31, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 31, 2020 AITU
SOU EXTENSION 5 FILED
Dec 11, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 11, 2020 EEXT
ASSIGNED TO EXAMINER
Sep 25, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2020 EXRA
SOU EXTENSION 4 GRANTED
Jun 22, 2020 EX4G
SOU EXTENSION 4 FILED
Jun 22, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 22, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 27, 2019 EXRA
SOU EXTENSION 3 GRANTED
Nov 25, 2019 EX3G
SOU EXTENSION 3 FILED
Nov 25, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 25, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 7, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jun 5, 2019 EX2G
SOU EXTENSION 2 FILED
Jun 5, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 5, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jan 3, 2019 EX1G
SOU EXTENSION 1 FILED
Jan 3, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 3, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 17, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 22, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 22, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 2, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2017 GNRN
NON-FINAL ACTION E-MAILED
Oct 10, 2017 GNRT
NON-FINAL ACTION WRITTEN
Oct 10, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2017 NWOS
NEW APPLICATION ENTERED
Jun 29, 2017 NWAP